Feline Infectious Peritonitis (FIP) has long been challenging for veterinarians, leaving cat owners and veterinary professionals seeking treatment options on the black market due to a lack of better options. This year two compounded treatments became available for the first time in the United States. This course examines molnupiravir in particular, comparing it to alternative treatment options. Veterinary professionals will gain an understanding of FIP and its various presentations, the value of compounding in developing treatment solutions, and the role of compounded molnupiravir as a therapeutic option.  Led by FIP experts, the session will highlight independent third-party studies that support molnupiravir as a treatment option for FIP and discuss appropriate usage guidelines for managing the different forms of FIP.  By the end of this session, attendees will have a comprehensive grasp of how compounded molnupiravir can be integrated into their treatment arsenal, improving patient outcomes and expanding their options to treat FIP.

_1743164814186